Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients

Inclusion Criteria: * Male or female patients ≥ 18 years. * Have chronic kidney disease per K/DOQI guidelines. * No change in EPO status during study. * Baseline hemoglobin of ≤ 11.0 g/dl. Exclusion Criteria: * Women who are pregnant or lactating. * Received another investigational drug or device within 30 days. * Recent parenteral or oral iron therapy. * Patients with active GI bleeding or acute bleeding within 4 weeks. * Patients that have other causes of anemia. * Major surgery within 30 days or anticipated or planned major surgery during the study. * Patients whose EPO status changes while on study. * Patients with active infections. * Recent blood transfusions. * Patients with any known allergies to iron products.